ABL Bio

298380.KQ

120.74 USD

4.95

+4.27%

Overview

Last close

120.74 usd

Market cap

5.86B usd

52 week high

120.74 usd

52 week low

15.54 usd

Target price

70.03 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

97.0708

Price/Book Value

44.3566

Enterprise Value

5.45B usd

EV/Revenue

90.4721

EV/EBITDA

-32.1061

Key financials

Revenue TTM

60.22M usd

Gross Profit TTM

60.18M usd

EBITDA TTM

-18.22M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

167.77M usd

Net debt

N/A usd

About

ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is based in Seoul, South Korea.